KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) EBT Margin: 2009-2025

Historic EBT Margin for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to 31.19%.

  • Idexx Laboratories' EBT Margin rose 55.00% to 31.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.56%, marking a year-over-year increase of 213.00%. This contributed to the annual value of 28.48% for FY2024, which is 51.00% down from last year.
  • As of Q3 2025, Idexx Laboratories' EBT Margin stood at 31.19%, which was down 4.49% from 32.66% recorded in Q2 2025.
  • Idexx Laboratories' EBT Margin's 5-year high stood at 32.66% during Q2 2025, with a 5-year trough of 19.88% in Q2 2022.
  • Moreover, its 3-year median value for EBT Margin was 30.30% (2023), whereas its average is 29.52%.
  • Per our database at Business Quant, Idexx Laboratories' EBT Margin crashed by 1,059bps in 2022 and then skyrocketed by 1,042bps in 2023.
  • Idexx Laboratories' EBT Margin (Quarterly) stood at 23.95% in 2021, then skyrocketed by 178bps to 25.73% in 2022, then skyrocketed by 85bps to 26.58% in 2023, then rose by 28bps to 26.87% in 2024, then spiked by 55bps to 31.19% in 2025.
  • Its EBT Margin was 31.19% in Q3 2025, compared to 32.66% in Q2 2025 and 31.06% in Q1 2025.